January 4, 2018 / 12:34 PM / Updated 9 minutes ago BRIEF-Alimera Sciences Receives Acceptance Of Filing To Obtain Approval For Iluvien Reuters Staff 1 Min Read 
Jan 4 (Reuters) - Alimera Sciences Inc: 
* ALIMERA SCIENCES RECEIVES ACCEPTANCE OF FILING TO OBTAIN APPROVAL FOR ILUVIENÂ® NON-INFECTIOUS POSTERIOR UVEITIS INDICATION IN EUROPE Source text for Eikon: Further company coverage: